Erech Finance (EFNC-M.TA)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in ILSTTM unavailable| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | ILS m | 10 | 13 | 11 | 0 | - | 0 | - | - |
| Operating profit | ILS m | -7 | - | ||||||
| Net profit | ILS m | 1 | 1 | -25 | -25 | - | -7 | - | - |
| EPS reported | ILS | -2.60 | - | ||||||
| Operating cashflow per share | ILS | -0.89 | - | ||||||
| Capex per share | ILS | 0.00 | - | ||||||
| FCF per share | ILS | -0.89 | - | ||||||
| Free cash flow | ILS m | -2 | - | ||||||
| Net debt | ILS m | 16 | - | ||||||
| Book value equity | ILS m | -8 | - | ||||||
| Book value per share | ILS | -3.07 | - | ||||||
| Number of shares | m | 2.61 | - | ||||||
| DPS (TTM paid) | ILS | 0.00 | - |
Financial summary
Financials in ILSTTM unavailable| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | -0.42 | - | ||||||
| P/S LTM | x | 34.49 | - | ||||||
| P/FCF LTM | x | -1.46 | - | ||||||
| EV/EBITDA LTM | x | -2.85 | - | ||||||
| EV/Sales LTM | x | 196.45 | - | ||||||
| Earnings Yield LTM | % | -2.01% | - | ||||||
| FCF Yield | % | -68.64% | - | ||||||
| Quality | |||||||||
| ROE | % | +84.79% | - | ||||||
| ROIC | % | -85.15% | - | ||||||
| Operating margin | % | -68.89% | - | ||||||
| Gross margin | % | -14.16% | - | ||||||
| FCF/Sales | % | -2367.35% | - | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -65.25% | - | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | - | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | - | ||||||
| FCF/Debt | x | -0.15 | - | ||||||
| Net Debt/EBITDA | x | -2.35 | - | ||||||
| EBIT/Net interest | x | -259.65 | - | ||||||
| Net debt/market cap | % | +4.71% | - | ||||||
| Net debt/Equity | x | -1.97 | - | ||||||
| Gross debt/equity | x | -1.99 | - | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Erech Finance Cahalacha Ltd, alongside its associated companies, extends lending and credit provisions to a diverse clientele within Israel, including small and medium-sized businesses, community organizations, and private individuals. Furthermore, the firm has a notable involvement in the biotechnological sector, concentrating on the advancement of pharmaceutical solutions for juvenile diabetes and various cancer types. Established in 1998, its operational base is situated in Jerusalem, Israel.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Erech Finance Cahalacha Ltd, alongside its associated companies, extends lending and credit provisions to a diverse clientele within Israel, including small and medium-sized businesses, community organizations, and private individuals. Furthermore, the firm has a notable involvement in the biotechnological sector, concentrating on the advancement of pharmaceutical solutions for juvenile diabetes and various cancer types. Established in 1998, its operational base is situated in Jerusalem, Israel.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free